Phase II study of high dose weekly intravenous human lymphoblastoid interferon in renal cell carcinoma. A study of the National Cancer Institute of Canada Clinical Trials Group.

por Eisenhauer, E. A., Silver, H. K., Venner, P. M., Thirlwell, M. P., Weinerman, B., Coppin, C. M.
Publicado 1987